Skip to main content
. 2010 Aug 6;192(20):5312–5318. doi: 10.1128/JB.00832-10

TABLE 1.

Plasmids, B. subtilis strains, and oligonucleotides used in this study

Plasmid, strain, or oligonucleotide Relevant construction, genotype, or sequence (5′-3′) Source or referenceb
Plasmids
    pBluescript II KS(+) Multipurpose cloning/in vitro transcription phagemid vector, bla Stratagene
    pMAD Plasmid used for allelic replacement in Gram-positive bacteria, bla, erm 2
    pLitmus29 Multipurpose cloning/in vitro transcription phagemid vector, bla New England Biolabs
    pMS38 pLitmus29 derivative used as a source of chloramphenicol resistance cassette, bla, cat 35
    pJL3 pLitmus29 derivative used as a source of kanamycin resistance cassette, bla, kan This work
    pMJ1 pBluescript II KS(+) derivative harboring the msmX coding region, bla This work
    pMJ2 pMJ1 derivative used for the creation of msmX-null mutations, bla, cat This work
    pMJ6 pMAD derivative used for the creation of araN in-frame deletion mutants, bla, erm This work
    pMJ7 pBluescript II KS(+) derivative harboring the promoterless araE coding region, bla This work
    pMJ10 Integrative plasmid used for the creation of area-null mutations, bla, kan This work
    pMJ11 Integrative plasmid used for the creation of araNPQ in-frame deletion mutants, bla, erm This work
B. subtilis strains
    168T+ Prototroph F. E. Young
    IQB206 ΔaraL-abfA::spc 23
    IQB495 ΔmsmX::cat pMJ2a→168T+
    IQB496 ΔaraN pMJ6→168T+
    IQB608 araE::kan pMJ10a→168T+
    IQB609 ΔmsmX::cat araE::kan pMJ10a→IQB495
    IQB610 ΔaraN araE::kan pMJ10a→IQB496
    IQB611 ΔaraNPQ pMJ11→168T+
Oligonucleotides
    ARA422 TATTGAGCTCTCAGGGATAGATATCAAATCG
    ARA423 CATCGGTACCATTCTGAGATTTTCAATAGC
    ARA426 GCGGATCCCTTTGGTGACATGCTCGG
    ARA427 CGCTTTCACTTTTTGAATGGGCTGCGTTACCCCTTCCATTCGAGGTGCGGG
    ARA428 CCCGCACCTCGAATGGAAGGGGTAACGCAGCCCATTCAAAAAGTGAAAGCG
    ARA429 GCTTAGTACTGCTCTTTCGGCACATTTTGC
    ARA448 GATAAAGTACTTTTCGAAAAAAGTCATTTTTTTCATCTGCGTTACCCCTTC
    ARA449 GAAGGGGTAACGCAGATGAAAAAAATGACTTTTTTCCAAAAGTACTTTATC
    ARA450 GGCATGCGCATGTTTGAGCTGCCGCAGGC
    ARA467 CCAGCAATATTTTATCC
    ARA488 CAAATTTCGGTACCTCACAGCG
a

Transformation was carried out with linearized DNA. The restriction sites used are underlined.

b

The arrows indicate transformation and point from donor DNA to the recipient strain.